Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences
What if the future of biotech is actually late-stage execution?
Welcome to our first video episode of the Biorasi Few & Far Between podcast with your host, Chris O’Brien. Today, we welcome guest Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences. We’ll be covering a myriad of biotech topics, from “business athletes” to the role of the operating company in the drug development industry. We’ll also be premiering our lightning round - quick questions and inspired answers from our podcast guests.
Okay, let’s start the podcast!
--------
1:01:16
--------
1:01:16
Episode 62: Ken Suzuki, Chief Marketing Officer at Nautilus Biotechnology
When is the right time for a biotech to bring in a Chief Marketing Officer/CMO?
Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Ken Suzuki, Chief Marketing Officer at Nautilus Biotechnology. Listen in as we access the marketer inside each of us, discuss how knowing people might be more important than business and finance, and follow the steps to maintain the fine balance between marketing and reality.
Let's start the podcast!
--------
44:15
--------
44:15
Episode 61: Woody Bryan, President and CEO of Revolo Biotherapeutics
Why is a feather-light touch important in fighting infections?
Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Woody Bryan, President and CEO of Revolo Biotherapeutics. Tune in as we press the reset button on the human immune system, explore upstream and downstream levers for treating autoimmune diseases, and how to stay competitive in the biotech industry.
Let's start the podcast!
--------
45:18
--------
45:18
Episode 60: Part Two: Yochi Slonim, Co-Founder and CEO at Anima Biotech
Can AI see and talk to human cells? Find out in today's episode of the Biorasi Few & Far Between podcast.
Host Chris O'Brien welcomes Yochi Slonim, Co-Founder and CEO at Anima Biotech, to the podcast. Get ready for part two of this special two-part episode as we touch on smarter LLMs, evolved AI agents, and connecting data to real-world biology.
Okay, let's start the podcast!
--------
42:11
--------
42:11
Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech
What do software bugs and human cells have in common? Find out in today's episode of the Biorasi Few & Far Between podcast.
Host Chris O'Brien welcomes Yochi Slonim, Co-Founder and CEO at Anima Biotech, to the podcast. Tune in to part one of this special two-part episode as we double-click on #AIagents, building neural networks, and syncing visual biology with real-world biology.
Okay, let's start the podcast!
About Few & Far Between: Conversations from the Front Lines of Drug Development
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
Listen to Few & Far Between: Conversations from the Front Lines of Drug Development, The School of Greatness and many other podcasts from around the world with the radio.net app
South Africa